WHWK Whitehawk Therapeutics, Inc.: institutional ownership and insider trading
82 funds reported holding $202M of Whitehawk Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $41.1M, with 28 new positions and 12 funds selling out; over the last 12 months insiders bought $0 and sold $2.58M on the open market; over its last four quarters it reported revenue of $0 and net income of −$79.8M.
WHWK revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$16.6M, EPS -0.20
- Quarter ended Mar 31, 2026: revenue $0, net income −$22.2M, EPS -0.32
- Quarter ended Dec 31, 2025: revenue $0, net income −$23.3M, EPS -1.14
- Quarter ended Sep 30, 2025: revenue $0, net income −$17.7M, EPS -0.26
Famous investors holding WHWK
- Renaissance Technologies (Renaissance Technologies): $1.90M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.74M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.36M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $138K, 0.0% of the portfolio
Largest institutional holders of WHWK
- Yu Fan — $22.3M
- ACUTA CAPITAL PARTNERS, LLC — $21.5M
- QVT Financial LP — $21.1M
- SUVRETTA CAPITAL MANAGEMENT, LLC — $19.7M
- ORBIMED ADVISORS LLC — $18.0M
- Avoro Capital Advisors LLC — $13.1M
- Siren, L.L.C. — $10.7M
- KVP Capital Advisors, LP — $9.92M
- BlackRock, Inc. (BLK) — $8.81M
- VANGUARD CAPITAL MANAGEMENT LLC — $6.36M
Recent WHWK insider trades
- Apr 16, 2026: Giacobello Scott M. sold 218,600 shares ($882K)
- Apr 14, 2026: Ball Bryan sold 118,849 shares ($428K)
- Apr 10, 2026: Ball Bryan sold 56,596 shares ($201K)
- Apr 9, 2026: Lennon David James sold 14,500 shares ($49.0K)
5%+ owners
- Behzad Aghazadeh: 20.0% (Schedule 13D/A, filed May 14, 2026)
- Fan Yu: 9.4% (Schedule 13G/A, filed Aug 14, 2026)
- ANUPAM DALAL: 9.0% (Schedule 13D/A, filed May 18, 2026)
- OrbiMed Advisors LLC: 7.3% (Schedule 13G/A, filed Aug 14, 2026)